Location History:
- Isle, FR (2014)
- Isles, FR (2018)
Company Filing History:
2 out of 48 
1 out of 5,099 
1 out of 2 Years Active: 2014-2018
Title: Michel Cogne: Innovator in Transgenic Mammal Research
Introduction
Michel Cogne is a prominent inventor based in Isles, France. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human mammals for medical applications. With a total of 2 patents, his work focuses on producing chimeric human immunoglobulin E antibodies and humanized class IgA antibodies.
Latest Patents
Cogne's latest patents include groundbreaking inventions. The first patent, titled "Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies," relates to a transgenic non-human mammal that comprises human immunoglobulin mu and epsilon heavy-chain constant transgenes. This invention is designed for producing chimeric human immunoglobulin E antibodies specific for an antigen of interest. The second patent, "Non-human transgenic mammal for the constant region of the class A human immunoglobulin heavy chain and applications thereof," involves a non-human transgenic mammal with an IgH locus modified for the production of humanized class IgA antibodies.
Career Highlights
Throughout his career, Michel Cogne has worked with esteemed institutions such as Université De Limoges and the Centre National De La Recherche Scientifique. His research has significantly advanced the understanding of immunoglobulin production and its applications in medicine.
Collaborations
Cogne has collaborated with notable colleagues, including Christophe Sirac and Micael Bardel. These partnerships have contributed to the success of his research and innovations.
Conclusion
Michel Cogne's work in transgenic mammal research has paved the way for advancements in antibody production. His contributions are vital to the field of biotechnology and hold promise for future medical applications.